ASRT
Assertio Holdings, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.50
+0.00%Margins
Gross margin
44.3%
EBITDA margin
-5.7%
EBIT margin
-22.3%
Net margin
-34.9%
FCF margin
-6.9%
-47.2%
Return on equity
-16.9%
Return on assets
-19.6%
Return on invested capital
0.43x
Asset turnover
-$7.1M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026